We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
CYSLTR2
  • TISSUE

  • CELL

  • PATHOLOGY

PATHOLOGY ATLAS

GENE/PROTEIN

Antibody validation

Dictionary

Level of antibody staining/expression





High
Medium
Low
Not detected

GENERAL INFORMATION

Gene name

CYSLTR2

Gene description

Cysteinyl leukotriene receptor 2

Protein class

FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins

Predicted localization

Intracellular,Membrane

Number of transcripts

5
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

RNA category

TCGA (cancer tissue):Group enriched (melanoma, renal cancer, thyroid cancer)
HPA (cell line):Cell line enriched (HDLM-2)
HPA (normal tissue):Tissue enhanced (placenta, seminal vesicle)

Protein evidence

Evidence at protein level

Protein expression
normal tissue

Cytoplasmic and membranous expression in most tissues.

ANTIBODY IHC RELIABILITY

Data reliability
description

Antibody staining mainly not consistent with RNA expression data.

Reliability score

Uncertain based on 1 antibody.
HPA046528
SHOW MORE

PROGNOSTIC SUMMARY

Gene product is not prognostic.
Show all

RNA EXPRESSION OVERVIEW

TCGA dataset
RNA cancer category: Group enriched (melanoma, renal cancer, thyroid cancer)

PROTEIN EXPRESSION

Colorectal cancer
Breast cancer
Prostate cancer
Lung cancer
Liver cancer

STAINING SUMMARY

HPA046528

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Most cancer tissues displayed moderate to strong cytoplasmic staining with additional membranous positivity in several cases. Malignant gliomas, lymphomas and melanomas as well as skin cancers were mainly negative.

GENE INFORMATION

Gene name

CYSLTR2 (HGNC Symbol)

Synonyms

CysLT(2), CYSLT2R

Description

Cysteinyl leukotriene receptor 2 (HGNC Symbol)

Entrez gene summary

The cysteinyl leukotrienes LTC4, LTD4, and LTE4 are important mediators of human bronchial asthma. Pharmacologic studies have determined that cysteinyl leukotrienes activate at least 2 receptors, the protein encoded by this gene and CYSLTR1. This encoded receptor is a member of the superfamily of G protein-coupled receptors. It seems to play a major role in endocrine and cardiovascular systems. [provided by RefSeq, Jul 2008]

Chromosome

13

Cytoband

q14.2

Chromosome location (bp)

48653711 - 48711226

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000152207 (version 83.38)

Entrez gene

57105

UniProt

Q9NS75 (UniProt - Evidence at protein level)

neXtProt

NX_Q9NS75

Antibodypedia

CYSLTR2 antibodies

PROTEIN BROWSER

CYSLTR2-001
CYSLTR2-002
CYSLTR2-003
CYSLTR2-004
CYSLTR2-005

PROTEIN INFORMATION

Splice variant

UniProt

Protein class

Gene ontology

Length & mass

Signal peptide
(predicted)

Transmembrane regions
(predicted)

CYSLTR2-001
ENSP00000282018
ENST00000282018
Q9NS75 [Direct mapping]
Cysteinyl leukotriene receptor 2
Q5KU17 [Target identity:100%; Query identity:100%]
Cysteinyl leukotriene receptor 2; G-protein coupled receptor protein; cDNA FLJ78284, highly similar to Homo sapiens cysteinyl leukotriene receptor 2 (CYSLTR2), mRNA
Show all
G-protein coupled receptors
   GPCRs excl olfactory receptors
Predicted membrane proteins
   Prediction method-based
   Membrane proteins predicted by MDM
   MEMSAT3 predicted membrane proteins
   MEMSAT-SVM predicted membrane proteins
   Phobius predicted membrane proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
   TMHMM predicted membrane proteins
   GPCRHMM predicted membrane proteins
   # TM segments-based
   7TM proteins predicted by MDM
FDA approved drug targets
   Small molecule drugs
Show all
GO:0001631 [cysteinyl leukotriene receptor activity]
GO:0004930 [G-protein coupled receptor activity]
GO:0004974 [leukotriene receptor activity]
GO:0005515 [protein binding]
GO:0005575 [cellular_component]
GO:0005886 [plasma membrane]
GO:0005887 [integral component of plasma membrane]
GO:0006955 [immune response]
GO:0007186 [G-protein coupled receptor signaling pathway]
GO:0007200 [phospholipase C-activating G-protein coupled receptor signaling pathway]
GO:0007218 [neuropeptide signaling pathway]
GO:0008528 [G-protein coupled peptide receptor activity]
GO:0010942 [positive regulation of cell death]
GO:0016020 [membrane]
GO:0016021 [integral component of membrane]
GO:0045766 [positive regulation of angiogenesis]
GO:0061737 [leukotriene signaling pathway]
GO:0070374 [positive regulation of ERK1 and ERK2 cascade]
Show all
346 aa
39.6 kDa
No 7
CYSLTR2-002
ENSP00000477930
ENST00000614739
Q9NS75 [Direct mapping]
Cysteinyl leukotriene receptor 2
Q5KU17 [Target identity:100%; Query identity:100%]
Cysteinyl leukotriene receptor 2; G-protein coupled receptor protein; cDNA FLJ78284, highly similar to Homo sapiens cysteinyl leukotriene receptor 2 (CYSLTR2), mRNA
Show all
G-protein coupled receptors
   GPCRs excl olfactory receptors
Predicted membrane proteins
   Prediction method-based
   Membrane proteins predicted by MDM
   MEMSAT3 predicted membrane proteins
   MEMSAT-SVM predicted membrane proteins
   Phobius predicted membrane proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
   TMHMM predicted membrane proteins
   GPCRHMM predicted membrane proteins
   # TM segments-based
   7TM proteins predicted by MDM
FDA approved drug targets
   Small molecule drugs
Show all
GO:0001631 [cysteinyl leukotriene receptor activity]
GO:0004930 [G-protein coupled receptor activity]
GO:0004974 [leukotriene receptor activity]
GO:0005515 [protein binding]
GO:0005575 [cellular_component]
GO:0005886 [plasma membrane]
GO:0005887 [integral component of plasma membrane]
GO:0006955 [immune response]
GO:0007186 [G-protein coupled receptor signaling pathway]
GO:0007200 [phospholipase C-activating G-protein coupled receptor signaling pathway]
GO:0007218 [neuropeptide signaling pathway]
GO:0008528 [G-protein coupled peptide receptor activity]
GO:0016021 [integral component of membrane]
GO:0061737 [leukotriene signaling pathway]
Show all
346 aa
39.6 kDa
No 7
CYSLTR2-003
ENSP00000482041
ENST00000617562
A4ZKH2 [Direct mapping]
Cysteinyl leukotriene receptor 2; Cysteinyl leukotriene receptor 2 splice variant I; Cysteinyl leukotriene receptor 2 splice variant II; Cysteinyl leukotriene receptor 2 splice variant III; Cysteinyl leukotriene receptor 2 splice variant IV; Cysteinyl leukotriene receptor 2 splice variant V; Cysteinyl leukotriene receptor 2 splice variant VI; Cysteinyl leukotriene receptor 2 splice variant VII; Cysteinyl leukotriene receptor 2 splice variant VIII
Show all
Predicted intracellular proteins
Show all
15 aa
1.7 kDa
No 0
CYSLTR2-004
ENSP00000479446
ENST00000622559
A4ZKH2 [Direct mapping]
Cysteinyl leukotriene receptor 2; Cysteinyl leukotriene receptor 2 splice variant I; Cysteinyl leukotriene receptor 2 splice variant II; Cysteinyl leukotriene receptor 2 splice variant III; Cysteinyl leukotriene receptor 2 splice variant IV; Cysteinyl leukotriene receptor 2 splice variant V; Cysteinyl leukotriene receptor 2 splice variant VI; Cysteinyl leukotriene receptor 2 splice variant VII; Cysteinyl leukotriene receptor 2 splice variant VIII
Show all
Predicted intracellular proteins
Show all
15 aa
1.7 kDa
No 0
CYSLTR2-005
ENSP00000482031
ENST00000621321
A4ZKH2 [Direct mapping]
Cysteinyl leukotriene receptor 2; Cysteinyl leukotriene receptor 2 splice variant I; Cysteinyl leukotriene receptor 2 splice variant II; Cysteinyl leukotriene receptor 2 splice variant III; Cysteinyl leukotriene receptor 2 splice variant IV; Cysteinyl leukotriene receptor 2 splice variant V; Cysteinyl leukotriene receptor 2 splice variant VI; Cysteinyl leukotriene receptor 2 splice variant VII; Cysteinyl leukotriene receptor 2 splice variant VIII
Show all
Predicted intracellular proteins
Show all
15 aa
1.7 kDa
No 0

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.